Abstract
Screening for aneuploidies instead of direct invasive diagnosis is recommended in twin pregnancies; however, it is complicated by several factors. While monozygotic twins are genetically identical and only one risk estimation is provided for the whole pregnancy, dizygotic twins, whose genetics are different, require a different risk estimation for each fetus. The challenge in prenatal diagnosis is that zygosity is rarely known, so chorionicity, as a proxy, must be used instead. Several methods have been used to screen for aneuploidies in twin pregnancies. Screening by maternal age alone is currently not recommended because of its poor performance; however, screening by fetal nuchal translucency thickness, the first trimester combined test, or cell-free DNA testing in maternal blood are effective methods of screening which show similar performance in twin pregnancies as compared to singleton pregnancies. However, specific considerations must be taken when using these methods in screening for aneuploidies in twin pregnancies. The performance of the second-trimester quadruple test is much poorer in twin than in singleton pregnancies. Therefore, its use should be limited to those cases where other methods are unavailable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol. 2017;49:714–20.
Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302–14.
van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, de Die-Smulders CEM, Duin LK, Faas BHW, Feenstra I, Haak MC, Hoffer MJV, den Hollander NS, Hollink IHIM, Jehee FS, Knapen MFCM, Kooper AJA, van Langen IM, Lichtenbelt KD, Linskens IH, van Maarle MC, Oepkes D, Pieters MJ, Schuring-Blom GH, Sikkel E, Sikkema-Raddatz B, Smeets DFCM, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Ven AJEM, van Zelderen-Bhola SL, Henneman L, Galjaard RH, Van Opstal D, Weiss MM, Dutch NIPT Consortium. TRIDENT-2: National implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in The Netherlands. Am J Hum Genet. 2019;105:1091–101.
Nicolaides KH, Syngelaki A, del Mar GM, Quezada MS, Zinevich Y. Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood. Fetal Diagn Ther. 2014;35:212–7.
Chitty LS, Mason S, Barrett AN, McKay F, Lench N, Daley R, Jenkins LA. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn. 2015;35:656–62.
Smith-Jensen S, Permin M, Philip J, Lundsteen C, Zachary JM, Fowler SE, Grüning K. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992;340:1237–44.
Evans MI, Goldberg JD, Dommergues M, Wapner RJ, Lynch L, Dock BS, et al. Efficacy of second-trimester selective termination for fetal abnormalities: international collaborative experience among the world’s largest centers. Am J Obstet Gynecol. 1994;171:90–4.
Spencer K, Kagan KO, Nicolaides KH. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn. 2008;28:49–52.
Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn. 2000;20:91–5.
Madsen HN, Ball S, Wright D, Tørring N, Petersen OB, Nicolaides KH, Spencer K. A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol. 2011;37:38–47.
Galeva S, Gil MM, Konstantinidou L, Akolekar R, Nicolaides KH. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol. 2019;53:804–9.
Gil MM, Galeva S, Jani J, Konstantinidou L, Akolekar R, Plana MN, Nicolaides KH. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of the Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol. 2019;53:734–42.
Judah H, Gil MM, Syngelaki A, Galeva S, Jani J, Akolekar R, Nicolaides KH. Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta-analysis. Ultrasound Obstet Gynecol. 2021;58:178–89.
Gil MM, Rodríguez-Fernández M, Elger T, Akolekar R, Syngelaki A, De Paco MC, Molina FS, Gallardo Arocena M, Chaveeva P, Persico N, Accurti V, Kagan KO, Prodan N, Cruz J, Nicolaides KH. Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis. Ultrasound Obstet Gynecol. 2021;59(2):162–8. https://doi.org/10.1002/uog.24826.
De Paepe ME. Chapter 5: Multiple gestation: the biology of twinning. In: Lockwood C, et al., editors. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 8th ed. Amsterdam: Elsevier; 2018. p. 68–80.e2.
Wøjdemann KR, Larsen SO, Shalmi AC, Sundberg K, Tabor A, Christiansen M. Nuchal translucency measurements are highly correlated in both mono- and dichorionic twin pairs. Prenat Diagn. 2006;26:218–20.
Nicolaides KH. The 11–13 weeks scan. 2nd ed. New Delhi: The Fetal Medicine Foundation; 2004. https://www.fetalmedicine.org/education/the-11-13-weeks-scan
Baldwin VJ. Anomalous development of twins. In: Baldwin VJ, editor. Pathology of multiple pregnancy. New York: Springer; 1994. p. 169–97.
Burn J. Disturbance of morphological laterality in humans. Ciba Found Sym. 1991;162:282–96.
Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Br J Obstet Gynaecol. 1996;103:999–1003.
Wright D, Syngelaki A, Staboulidou I, de Cruz JJ, Nicolaides KH. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn. 2011;31:16–21.
Audibert F, Gagnon A, Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can. 2011;33:754–67.
Nicolaides KH. Screening for fetal aneuploidies at 11–13 weeks. Prenat Diagn. 2011;31:7–15.
Prats P, Rodríguez I, Comas C, Puerto B. Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis. Prenat Diagn. 2014;34:1077–83.
Cuckle H. Down’s syndrome screening in twins. J Med Screen. 1998;5:3–4.
Niles KM, Murji A, Chitayat D. Prolonged duration of persistent cell-free fetal DNA from vanishing twin. Ultrasound Obstet Gynecol. 2018;52:547–8.
Chen M, Su F, Wang J, Zhou L, Liu Q, Chai X, Yuan Y, Cen M, Wu Y, Wang Y, Chen F, Zhang Y, Chen D, Gao Y. Temporal persistence of residual fetal cell-free DNA from a deceased cotwin after selective fetal reduction in dichorionic diamniotic twin pregnancies. Prenat Diagn. 2021;41:1602–10.
Zou Y, Cui L, Xue M, Yan J, Huang M, Gao M, Gao X, Gao Y, Chen ZJ. Applications of noninvasive prenatal testing in vanishing twin syndrome pregnancies after treatment of assisted reproductive technology in a single center. Prenat Diagn. 2021;41:226–33.
Khalil A, Rodgers M, Baschat A, Bhide A, Gratacos E, Hecher K, Kilby MD, Lewi L, Nicolaides KH, Oepkes D, Raine-Fenning N, Reed K, Salomon LJ, Sotiriadis A, Thilaganathan B, Ville Y. ISUOG Practice Guidelines: role of ultrasound in twin pregnancy [Erratum in: Ultrasound Obstet Gynecol 2018; 52:140.]. Ultrasound Obstet Gynecol. 2016;47:247–63.
Chaveeva P, Wright A, Syngelaki A, Konstantinidou L, Wright D, Nicolaides KH. First-trimester screening for trisomies in pregnancies with vanishing twin. Ultrasound Obstet Gynecol. 2020;55:326–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gil, M.M., Chaveeva, P., Nicolaides, K.H. (2023). Screening of Aneuploidies in Twin Pregnancies. In: Di Renzo, G.C. (eds) Prenatal Diagnostic Testing for Genetic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-31758-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-31758-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31757-6
Online ISBN: 978-3-031-31758-3
eBook Packages: MedicineMedicine (R0)